RecruitingPhase 4NCT02803294

Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population

THE TORCH TRIAL：Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

2,000 participants

Start Date

Jun 1, 2016

Study Type

INTERVENTIONAL

Conditions

Symptomatic Aortic Stenosis

Summary

The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called transcatheter aortic valve replacement for people with symptomatic aortic stenosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREtranscatheter aortic valve replacement

Locations(1)

The Second Affiliated Hospital, School of Medicine at Zhejiang University

Hanzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02803294

Related Trials

Structured Shared Decision Making for Patients Undergoing SAVR or TAVR

NCT057111861 location

Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System

NCT0486180531 locations